60-day Federal Register Notice

8252

Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Centers for Disease Control and
Prevention

Centers for Disease Control and
Prevention

Notice of Closed Meeting

[60–Day–22–22CL; Docket No. CDC–2022–
0021]

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.

jspears on DSK121TN23PROD with NOTICES1

Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—CE22–009, Research
Grants for Preventing Violence and Violence
Related Injury (R01).
Date: May 10–11, 2022.
Time: 8:30 a.m., EDT–5:30 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Aisha L.
Wilkes, M.P.H., Scientific Review Official,
National Center for Injury Prevention and
Control, CDC, 4770 Buford Highway NE,
Mailstop S106–9, Atlanta, Georgia 30341,
Telephone (404) 639–6473, AWilkes@
cdc.gov.
The Director, Strategic Business Initiatives
Unit, Office of the Chief Operating Officer,
Centers for Disease Control and Prevention,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–03013 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P

VerDate Sep<11>2014

17:54 Feb 11, 2022

Jkt 256001

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Population-based Surveillance of
Outcomes, Needs, and Well-being of
Children and Adolescents with
Congenital Heart Defects (CHD). The
purpose of this collection is to provide
insight into public health questions that
remain for CHD and to develop services
and allocate resources to improve longterm health and well-being.
DATES: CDC must receive written
comments on or before April 15, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0021 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
SUMMARY:

Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS

FOR FURTHER INFORMATION CONTACT:

PO 00000

Frm 00026

Fmt 4703

Sfmt 4703

H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Population-based Surveillance of
Outcomes, Needs, and well-being of
Children and Adolescents with
Congenital Heart Defects—New—
National Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CHD are the most common type of
structural birth defects, affecting
approximately one in 110 live-born
children. Due to advances in survival,
there are approximately one million
children with CHD in the United States.
With vast declines in mortality from
pediatric heart disease over the past 30
years, it is vital to evaluate health,

E:\FR\FM\14FEN1.SGM

14FEN1

8253

Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
social, educational, and quality of life
outcomes beyond infancy and early
childhood. However, existing U.S.
population-based data are lacking on
these outcomes among those born with
CHD and the changes that may occur
with time and age. U.S. data is needed
to provide insight into the public health
questions that remain for this
population and to develop services and
allocate resources to improve long-term
health and well-being.
For this project, we will use data from
U.S. state birth defect surveillance
systems, or population-based studies
derived from them, to identify a
population-based sample of children
and adolescents 2–17 years of age born

We estimate receiving completed
surveys from 7,667 caregivers of
children and adolescents with CHD in
the birth defects surveillance systems.
To generate sufficient sample size,
accounting for non-response, from
caregivers up to 17 years after the birth
of their child with CHD, we intend to
sample 100% of eligible CHD cases
identified through select birth defect
surveillance systems. The survey takes
approximately 20 minutes to complete.
Therefore, we estimate the total annual
burden to be 2,556 hours. There are no
costs to participants other than their
time.

with CHD. We will then use state
databases and online search engines to
find current addresses for those
individuals and mail surveys to their
caregivers inquiring about the child’s
cardiac and other healthcare utilization,
barriers to healthcare, quality of life,
social and educational outcomes, and
transition of care from childhood to
adulthood, as well as needs and
experiences of the caregivers. The
information collected from this
population-based survey will be used to
inform current knowledge, allocate
resources, develop services, and,
ultimately, improve long-term health of
children and adolescents born with
CHD.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden
per response
(in hours)

Total burden
(in hours)

Form name

Caregivers of individuals aged 2–17
years with a CHD.

Survey questionnaire .......................

7,667

1

20/60

2,556

Total ...........................................

...........................................................

........................

........................

........................

2,556

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–03077 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30–Day–22–21IE]

Agency Forms Undergoing Paperwork
Reduction Act Review

jspears on DSK121TN23PROD with NOTICES1

Number of
responses per
respondent

Number of
respondents

Type of respondents

In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled’’ Understanding
Health System Approaches to Chronic
Pain Management’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on Sept. 27,
2021 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.

VerDate Sep<11>2014

18:55 Feb 11, 2022

Jkt 256001

The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting

PO 00000

Frm 00027

Fmt 4703

Sfmt 4703

‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Understanding Health System
Approaches to Chronic Pain
Management—New—National Center
for Injury Prevention and Control
(NCIPC), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC requests OMB approval for three
years for this new data collection. This
study is designed to evaluate the effects
of evidence-based guidelines related to
chronic pain management and opioid
prescribing, including access to
medications for opioid use disorder
(MOUD), for patients and clinicians in
primary care settings among a diverse
sample of health systems.
Since 1999, nearly 841,000 people
have died from drug overdose in the
United States. Over 70% of drug
overdose deaths in 2019 involved an
opioid. From 1999 to 2019, nearly
247,000 people died in the United
States from overdoses involving

E:\FR\FM\14FEN1.SGM

14FEN1